August 12, 2026
Boulevard Bio
Boulevard Bio, an NYC-based precision immunology startup, raised $65 million from Deerfield Management.
- Round
- Other
- Amount raised
- $65M
- Lead investor
- Deerfield Management
- Industry
- Biotechnology, Immunology
- Headquarters
- New York, United States
- Employees
- —
- Website
- boulevardbio.com
- View profile →
Source: Axios Pro Rata